30 October 2009
30 October 2009
Metabolix has completed a field trial of tobacco, genetically engineered to express polyhydroxyalkanoate (PHA) biobased polymers.
Metabolix obtained the necessary permits from the U.S. Department of Agriculture Animal Plant Health Inspection Service (APHIS) to perform an open air field trial in March of 2009 and field trial experiments were completed in early October.
The trial was performed on 0.8 acres of land and provided data and information relating to polymer production, with the best plants said to produce 3-5% PHA. This furthers development of Metabolix crop technologies for the co-production of biobased plastics in non-food bioenergy crops.
Dr. Oliver Peoples, Chief Scientific Officer of Metabolix, commented, ""The experience and knowledge we have gained during our tobacco field trial is laying the groundwork for planning and permitting activities for field trials in bioengineered, non-food oilseed and biomass crops producing PHA. We believe that our crop programs offer a number of commercialization options and hold significant potential. We are excited to continue to push this technology forward and believe it will ultimately support a diverse array of bioengineered, environmentally conscious and economically viable alternatives to petroleum-based products.""
The £50 million McLaren Composites Technology Centre (MCTC) nearing completion near Sheffield, UK, was inaugurated on 16 January.
Scott Bader is exhibiting its Crestabond structural adhesives at the Automotive Lightweight Technologies Expo in Tokyo, Japan, on 17-19 January 2018.
ELG Carbon Fibre will be exhibiting for the first time at the Automotive World Show in Tokyo on 17-19 January.